1. Inovio's COVID-19 vaccine funding axed as US says thanks but no thanks — Bristol Myers' next-gen immunology med busts Amgen's Otezla in head-to-head study — Could a souped-up version of existing Covid-19 tests be our shortcut to tracking variants?See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Quick Navigation Menu

Forum List